Atlas Trials

Surgery for Recurrent Glioblastoma

Clinical trial NCT02394626 · RECRUITING

Trial details

NCT number
NCT02394626
Sponsor
Insel Gruppe AG, University Hospital Bern
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Glioblastoma
Start date
2015-05-01
Primary completion
2028-12-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.